| SL No | Subtypes | Recommendations by -ACS, IASLC. | Non-surgical options -A | Surgical Options -B |
|---|---|---|---|---|
| 1. | Ground glass nodules | Defer surgery | Defer surgery | |
| Pulmonary metastases | ||||
| 2 | Carcinoids | Defer surgery | Defer surgery | |
| 3 | Mediastinal tumors- Thymoma | Defer surgery unless symptomatic | Defer surgery | |
| 4 | NSCLC | Defer surgery |
Defer surgery In adenocarcinoma- consider oral targeted therapy if suggested by mutational analysis |
Defer surgery |
| T1a/T1b and node negative | ||||
| 5 | NSCLC | Consider early surgery for operable tumors |
Neoadjuvant chemotherapy In adenocarcinoma- consider oral targeted therapy if suggested by mutational analysis |
Defer surgery until progression |
| T1c or above and cN0, cN1 | ||||
| 6 | Emergency indication- Bleeding/hemoptysis, obstructed airway | Consider non-invasive intervention procedures, if fails surgery | Consider non-invasive intervention procedures, if fails surgery |